Insulin Products Return to Non-Preferred Status on September 18, 2020

Insulin Products Return to Non-Preferred Status on September 18, 2020

FirstCare follows the Texas VDP formulary. VDP temporarily removed the non-preferred status on April 1, 2020 in response to reported drug shortages for insulin products in the "Hypoglycemics, Insulins" drug class. VDP will reverse this change in status because of sufficient availability in the market. VDP made this determination after verifying the current availability of the preferred insulin products, as well as the non-preferred insulin products through multiple sources such as ASHP, FDA, manufacturers, wholesalers, and pharmacies in various regions around Texas. Beginning September 18, 2020 the formulary will reflect the PDL status changes for all non-preferred insulin products. 

Updating to correct non-preferred status for Novolin Flexpen.
For additional information and a list of preferred PDL NDCs please click here.

Send to a Friend

* Required field

Captcha The math problem above is intended to reduce spam.